Chirongenix is committed to ensuring full compliance with the regulatory requirements set by the South African Health Products Regulatory Authority (SAHPRA) and the South African Pharmacy Council (SAPC) for the distribution of complementary medicines in South Africa. This process involves a strategic approach, including active engagement with both regulatory bodies, detailed documentation, and continuous efforts towards achieving and maintaining SAHPRA accreditation.
Chirogenix has partnered with specialist regulatory consultants, PrimeReg Consulting, to navigate the complex regulatory landscape in South Africa. This collaboration aims to ensure that Chirogenix adheres to all regulatory requirements and successfully secures the necessary licenses for distributing complementary medicines in the South African market. PrimeReg Consulting’s expertise in regulatory compliance is instrumental in guiding Chirogenix through the process, ensuring that all regulatory standards are met, and facilitating a smooth and efficient licensing process.